News/ News/ Oncology BMS agrees deal worth up to $1.56bn for Agenus’ TIGIT cancer drug Richard Staines Agenus, Bristol-Myers Squibb, cancer, lung cancer, R&D, TIGIT 0 Comment Bristol-Myers Squibb has paid $200 million, and promised up to $1.36 billion in “biobucks” for exclusive rights to Share X BMS agrees deal worth up to $1.56bn for Agenus’ TIGIT cancer drug https://pharmaphorum.com/news/bms-agrees-deal-worth-up-to-1-56bn-for-agenus-tigit-cancer-drug/
Agenus, Bristol-Myers Squibb, cancer, lung cancer, R&D, TIGIT
0 Comment
